Fair Richard A. 4
4 · Enliven Therapeutics, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Fair Richard A.
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option (right to buy)
2025-12-11+875,000→ 875,000 totalExercise: $18.77Exp: 2035-12-11→ Common Stock (875,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option will vest on December 11, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.